CYP19A1 and neoplasm: For an estrogen-dependent tumor, in consequence this implies that the secretion of factors leading to activation of promoter I.3/II-mediated aromatase expression in BAFs is not sufficient to secure a constant supply of estrogens for the tumor cells.